Home
#Global Trends
#Local Dynamics
#M&A
#Regulations
#Knowledge

Category: Uncategorized

A New Breakthrough in Duchenne Muscular Dystrophy Treatment: Promising Phase 3 Trial Results

07/12/2025 Published by vivi

A therapeutics company has announced positive topline results from its pivotal Phase 3 HOPE-3 clinical trial, evaluating the efficacy of... Read more

Tags: #Global Trends

Strategic Alliance: French Pharmaceutical Group Partners with Major Drugstore Chain

07/12/2025 Published by vivi

A reputable pharmaceutical corporation from France, with over seven decades of experience in the research, production, and distribution of healthcare... Read more

Category: Uncategorized

Tags: #Local Dynamics

Pharmaceutical Update: Regulatory Body Approves and Renews Nearly 600 Drug Licenses

07/12/2025 Published by vivi

The Pharmaceutical Management Agency under the Ministry of Health of Vietnam has announced a new list of approximately 600 drug... Read more

Category: Uncategorized

Tags: #Local Dynamics

Expanding Horizons: The Growth Journey of a Private Healthcare Group

07/12/2025 Published by vivi

The establishment of a specialized obstetrics and gynecology facility in Can Tho led to the formation of a healthcare group... Read more

Category: Uncategorized

Tags: #Local Dynamics

European Authorities Clear Novel Autoimmune Therapy for Myasthenia Gravis

06/12/2025 Published by vivi

The European Commission has granted authorization for nipocalimab, an immunoglobulin G (IgG) receptor antagonist developed by Johnson & Johnson, for... Read more

Category: Uncategorized

Tags: #Global Trends

Eli Lilly Secures Experimental Cancer Therapy from Scorpion in Up-to-$2.5 Billion Deal

06/12/2025 Published by vivi

Eli Lilly announced its plan to acquire an experimental cancer therapy from Scorpion Therapeutics for a total consideration of up... Read more

Category: Uncategorized

Tags: #M&A

📰 Novartis Acquires Anthos Therapeutics for Up to $3.1 Billion to Boost Cardiovascular Pipeline

06/12/2025 Published by vivi

The Swiss pharmaceutical giant Novartis has reached an agreement to acquire Anthos Therapeutics, a biopharmaceutical firm majority-owned by the life... Read more

Category: Uncategorized

Tags: #M&A

Merck Finalizes $3.4 Billion Acquisition, Enhancing Rare Tumor Portfolio

06/12/2025 Published by vivi

Merck has successfully completed its previously announced $3.4 billion acquisition of SpringWorks Therapeutics, a biopharmaceutical company based in Stamford, Connecticut.... Read more

Category: Uncategorized

Tags: #M&A